Company loses cancer gene patent case

Issue 
Yvonne D'Arcy whose campaign stopped a company from trying to patent a cancer gene.

A Queensland woman has won a High Court challenge against corporations owning human genes.

Yvonne D'Arcy took her fight against US-based biotech company Myriad Genetics to Australia's highest court. The company has a patent over the BRCA1 gene that is linked to an increased risk of hereditary breast and ovarian cancers.

A Queensland woman has won a High Court challenge against corporations owning human genes.

Yvonne D'Arcy took her fight against US-based biotech company Myriad Genetics to Australia's highest court. The company has a patent over the BRCA1 gene that is linked to an increased risk of hereditary breast and ovarian cancers.

Darcy's lawyers had argued that genetic material is a product of nature and is therefore not patent-able. Allowing corporations to own patents over human genes stifled cancer research, she said, and would allow them to charge exorbitant rates for patients who wish to be tested for the BRCA1 mutation.

In a unanimous decision on October 7, the High Court found that coding for a BRCA1 protein was not a “patentable invention”.

Like the article? Subscribe to Green Left now! You can also like us on Facebook and follow us on Twitter.

If you like our work, become a supporter

Green Left is a vital social-change project and aims to make all content available online, without paywalls. With no corporate sponsors or advertising, we rely on support and donations from readers like you.

For just $5 per month get the Green Left digital edition in your inbox each week. For $10 per month get the above and the print edition delivered to your door. You can also add a donation to your support by choosing the solidarity option of $20 per month.

Freecall now on 1800 634 206 or follow the support link below to make a secure supporter payment or donation online.